Status:
COMPLETED
Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)
Lead Sponsor:
Connolly, Stuart, M.D.
Collaborating Sponsors:
Abbott Medical Devices
Conditions:
Ventricular Tachycardia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is an open parallel design randomized trial of amiodarone plus a beta blocker vs a beta blocker alone vs sotalol for the prevention of ICD shocks in patients receiving an ICD for spontaneous or i...
Eligibility Criteria
Inclusion
- spontaneous or inducible ventricular tachycardia or fibrillation -
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
End Date :
October 1 2004
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00257959
Start Date
January 1 2001
End Date
October 1 2004
Last Update
July 27 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster University
Hamilton, Ontario, Canada